DEA’s Final Buprenorphine Rule: A Step Toward Expanding Telehealth Access for Opioid Use Disorder Treatment
Substance use disorder (SUD) treatment providers, particularly those focused on opioid use disorder (OUD), received significant news this week that could help expand access...
FTC Sues Substance Use Disorder Treatment Provider for Deceptive Advertising Practices
The Federal Trade Commission (FTC) has filed a lawsuit against Florida-based Evoke Wellness, accusing the substance use disorder (SUD) treatment provider of engaging in...
BlueSprig Pediatrics and Trumpet Behavioral Health Sued Over Alleged Sexual Assault by Therapist
BlueSprig Pediatrics, alongside its subsidiary Trumpet Behavioral Health, is currently embroiled in a serious legal battle after being sued for allegations of sexual assault...
Navigating the Landscape of Substance Use Disorder Treatment in 2024: Challenges, Breakthroughs, and Hope for the Future
The year 2024 in the substance use disorder (SUD) treatment industry has been a dynamic mix of formidable challenges, technological disruptions, and unexpected breakthroughs....
The Interconnectedness of Operational and Clinical Excellence
Jeff Rosen, who has spent eight years with Sunwave Health, brings a wealth of experience to the conversation. Sunwave Health is a leading behavioral...
The High Stakes of Behavioral Health Parity: Striving for Fair Access
The lack of behavioral health parity has long been a persistent issue in the United States, and its consequences for patients are profound and...
